|
90-minute Webcast on CD
Rx Class Action: Rheumatoid Arthritis Drugs Webcast held June 26, 2007. Now available on CD.
Some of the newest and most frequently advertised drugs used to treat rheumatoid arthritis—disease-modifying antirheumatic drugs called DMARDs—are expensive with dangerous side effect profiles. Hear about the broad continuum of medications available to treat RA effectively, with positive patient outcomes that won’t accelerate your drug spend.
Learning Objectives
Rheumatoid arthritis (RA) is a debilitating autoimmune disease that affects more than two million Americans, according to the American College of Rheumatology. Rx Class Action: Rheumatoid Arthritis Drugs is the first Webcast in a series on drug class management strategies that PBMI will offer in 2007.
This Webcast is designed to help human resource and benefits professionals, pharmacy professionals, PBM executives, and consultants to:
• Articulate the incidence of rheumatoid arthritis (RA)
• Review how this autoimmune disease impacts working Americans
• Describe the types of drugs used to treat RA
• Assess the economics of the drug classes used to manage RA
• Identify utilization management strategies to use RA drugs effectively
• Access online resources about diagnosing and treating RA
Speakers
Timothy Colligan, RPh, MS
Pharmacy Director
SummaCare
Timothy Colligan, RPh, MS, is pharmacy director for SummaCare, a managed care organization based in Akron, OH. SummaCare was named one of "America’s Best Health Plans" by U.S. News & World Report/NCQA in November 2006 For the second year, U.S.News & World Report and the National Committee for Quality Assurance (NCQA) joined together to rank hundreds of the nations health maintenance organizations and point-of-service plans. The plan provides health care to commercial, Medicare and Medicaid members in an 18-county service area in northeastern Ohio through a network of more than 6,000 providers and 30 hospitals.
Colligan began his career as a retail pharmacist. He had held positions of increasing responsibility in several areas of managed care pharmacy. Colligan also is a member of PBMI’s advisory board.
Patience White, MD
Chief Public Health Officer
Arthritis Foundation
Patience White, M.D. is the first Chief Public Health Officer for the Arthritis Foundation . She guides the public health role of the Foundation to improve the lives of the 46 million Americans with arthritis. A board-certified rheumatologist, Dr. White also serves as a professor of medicine and of pediatrics for George Washington University School of Medicine and Health Care Sciences. Her clinical passion is pediatric rheumatology. She completed her medical training, residency and fellowship at Harvard Medical School.
 CD $279
10% discount for PBMI members.
If you have questions, contact info@pbmi or call 480-730-0814.
|
